An In-situ Detection for MicroRNA

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

NCT03947736 ·Status: UNKNOWN

99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer

NCT05622240 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer

NCT00566085 ·Status: COMPLETED ·Phase: NA

miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment

NCT03779022 ·Status: UNKNOWN

Microbiome Immunotherapy Neoadjuvant Assessment

NCT06709651 ·Status: RECRUITING

Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy

NCT05649475 ·Status: UNKNOWN

MicroRNAs and Prognosis in Breast Cancer

NCT06555354 ·Status: COMPLETED

Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients

NCT07052734 ·Status: COMPLETED

Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma

NCT05151224 ·Status: UNKNOWN

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

NCT05923268 ·Status: COMPLETED ·Phase: NA

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

NCT04999826 ·Status: COMPLETED

Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer

NCT05417048 ·Status: UNKNOWN

Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery

NCT06595966 ·Status: RECRUITING

Clinical Application of CTDNA in Operable Breast Cancer Patients

NCT02797652 ·Status: UNKNOWN

Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer

NCT06876610 ·Status: RECRUITING

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

NCT06698679 ·Status: RECRUITING

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer

NCT05079074 ·Status: COMPLETED

Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors

NCT00625417 ·Status: COMPLETED ·Phase: NA

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

NCT02127073 ·Status: TERMINATED ·Phase: PHASE2

Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer

NCT02670668 ·Status: UNKNOWN ·Phase: NA

Breast Cancer Survivorship Biorepository

NCT05786664 ·Status: RECRUITING

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

NCT00897208 ·Status: COMPLETED

Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer

NCT00766454 ·Status: COMPLETED

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

NCT06979921 ·Status: ACTIVE_NOT_RECRUITING

Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy

NCT01198301 ·Status: COMPLETED